Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

New study links stress with biological disease markers in leukemia patients

New study links stress with biological disease markers in leukemia patients

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Patients with chronic lymphocytic leukemia have higher risk of melanoma, shows study

Patients with chronic lymphocytic leukemia have higher risk of melanoma, shows study

Portfolio diet reduces risk factors for cardiovascular disease

Portfolio diet reduces risk factors for cardiovascular disease

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Inflection Biosciences' dual mechanism inhibitor shows promise as treatment for CLL

Inflection Biosciences' dual mechanism inhibitor shows promise as treatment for CLL

Homogenous BTK occupancy assay used in tirabrutinib clinical studies

Homogenous BTK occupancy assay used in tirabrutinib clinical studies

New findings refine link between clonal hematopoiesis and blood cancer risk

New findings refine link between clonal hematopoiesis and blood cancer risk

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Researchers complete genomic map of chronic lymphocytic leukemia

Researchers complete genomic map of chronic lymphocytic leukemia

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Researchers test new cancer research model that may reduce cost and speed up studies

Researchers test new cancer research model that may reduce cost and speed up studies

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests

Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests

Research reveals immune suppressive role of soluble antibodies in tumor progression

Research reveals immune suppressive role of soluble antibodies in tumor progression

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia